This announcement is a separate document:
東曜藥業-B：有關 VIVO CAPITAL FUND VIII 向本公司一間附屬公司注資的 關連交易
TOT BIOPHARM-B: CONNECTED TRANSACTION IN RELATION TO CAPITAL INJECTION BY VIVO CAPITAL FUND VIII INTO A SUBSIDIARY OF THE COMPANY
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.